Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTJ13ST)

• DTT Name: Inward rectifier potassium channel Kir1.1 (KCNJ1) DTT Info
• Gene Name: KCNJ1

Molecule-Related Drug & Molecule List

52 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID26004420-Compound-U2014S0288042A	DM8FQJB	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-U2014S0288042C	DM8RJTQ	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140031349A	DMVQSYT	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140031349B	DM3M1NB	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140031349C	DMDP8J0	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140031349D	DMUD7IB	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140142115A	DMIXVNQ	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140142115B	DM07DC6	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140142115C	DMQ7Z5F	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140275020D	DMQ5AIT	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140275020E	DMH7JKI	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140309213A	DMH8M1D	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140309213B	DM0P4TA	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140336177D	DM4M2TU	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-US20140336177E	DMCRJO1	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2010129379A	DM37GMQ	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2010129379B	DM62A1H	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2010129379C	DMV3X64	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2012058116A	DMR9B2D	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2012058116B	DMD41UF	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2012058116C	DM2Y64W	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2012058134A	DMUX0SG	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2012058134B	DMGVXCL	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2012058134C	DM9AJVK	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013028474A	DMIV92A	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013028474B	DMCP0WF	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013028474C	DMTCPNY	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013039802A	DMT7GQ1	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013039802B	DMP130R	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013039802C	DMV7ISR	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013062892D	DMH7E38	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013062892E	DMMHLA9	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013062900A	DM5N9M4	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013062900B	DMIM8UF	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2013062900C	DMDZHAB	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014015495A	DMRDUS9	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014015495B	DMLH637	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014015495C	DMHA18O	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014015495D	DM3QO5R	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014085210A	DMY6JAB	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014085210B	DMTD0RK	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014085210C	DMKC6SA	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014099633D	DMJIZWR	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014099633E	DMSPG8Y	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014126944A	DM59INV	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014126944B	DMH0LBI	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014150132A	DMN1B3F	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014150132B	DMJX8WY	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2014150132C	DM2FDCT	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2015017305D	DMI30GA	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2015017305E	DMV4HQ5	N. A.	N. A.	Patented	[1]
PMID26004420-Compound-WO2015017305F	DMLV6IY	N. A.	N. A.	Patented	[1]

1 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
VU591	DMX9ED1	Discovery agent	N.A.	Investigative	[2]

References

• [1] Inhibitors of the renal outer medullary potassium channel: a patent review.Expert Opin Ther Pat. 2015;25(9):1035-51.
• [2] Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel. Mol Pharmacol. 2011 Jan;79(1):42-50.